Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Bacitracin recalled?

Yes — there is an active recall. 13 ongoing FDA recalls mention Bacitracin (25 total). Check the affected lots below.

Most common reason: cGMP deviation (12 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Bacitracin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Bacitracin recalls in 2026

9 initiated in 2026, 25 in total — newest first
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0642-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0641-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0637-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0636-2026
Class II · Moderate risk

Med Pride

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0635-2026
Class II · Moderate risk

Rapidol

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0633-2026
Class II · Moderate risk

Lil Drug Store

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0632-2026
Class II · Moderate risk

Circle K

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0631-2026
Class II · Moderate risk

Lucky Super Soft

CGMP Deviations; deficiencies observed during FDA inspection

Ongoing cGMP deviation Dabur India Limited D-0630-2026
Class II · Moderate risk

Rapidol

CGMP Deviations

Terminated cGMP deviation Kenil Healthcare Private Limited NDC 55758-440-02 D-0429-2025
Class II · Moderate risk

Ak-Poly-Bac

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Ongoing Stability / shelf life Akorn, Inc. D-0788-2023
Class II · Moderate risk

Triple Antibiotic Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0498-0750-36 D-1311-2022
Class II · Moderate risk

CVS Health

Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Terminated Wrong potency / content Product Quest Manufacturing LLC D-0073-2019
Class II · Moderate risk

Rite Aid Pharmacy

Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.

Terminated Wrong potency / content Product Quest Manufacturing LLC D-0067-2019